interleukin-1beta (163-171) has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 1 studies
| Studies (interleukin-1beta (163-171)) | Trials (interleukin-1beta (163-171)) | Recent Studies (post-2010) (interleukin-1beta (163-171)) | Studies (n-methyl-3,4-methylenedioxyamphetamine) | Trials (n-methyl-3,4-methylenedioxyamphetamine) | Recent Studies (post-2010) (n-methyl-3,4-methylenedioxyamphetamine) |
|---|---|---|---|---|---|
| 192 | 3 | 74 | 4,276 | 211 | 1,392 |
| Protein | Taxonomy | interleukin-1beta (163-171) (IC50) | n-methyl-3,4-methylenedioxyamphetamine (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.9351 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 1.1761 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 1.06 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.7609 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borcel, E; Colado, MI; Gutierrez-Lopez, MD; Mayado, A; O'Shea, E; Peraile, I; Torres, E | 1 |
1 other study(ies) available for interleukin-1beta (163-171) and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Evidence that MDMA ('ecstasy') increases cannabinoid CB2 receptor expression in microglial cells: role in the neuroinflammatory response in rat brain.
Topics: Analysis of Variance; Animals; Brain; CD11b Antigen; Chromatography, High Pressure Liquid; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Hallucinogens; In Vitro Techniques; Indoles; Interleukin-1beta; Male; Microglia; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Peptide Fragments; Rats; Receptor, Cannabinoid, CB2; Selective Serotonin Reuptake Inhibitors; Serotonin; Time Factors; Tritium | 2010 |